This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through October 6, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
medical-devices: Archive
Here's Why You Should Add OPKO Health Stock to Your Portfolio
by Zacks Equity Research
OPK benefits from RAYALDEE momentum, strategic deals and advancing trials amid stiff competition and dependence risks.
MASINegative Net Change MMSINegative Net Change WSTPositive Net Change OPKPositive Net Change
medical medical-devices
Can Sustained Strength in Water Drive ECL Stock Before Q3 Earnings?
by Zacks Equity Research
Ecolab's Water and Pest units show strength ahead of third-quarter 2025, but softness in Paper and macroeconomic headwinds may weigh on growth.
ECLPositive Net Change ESIPositive Net Change COIHYNegative Net Change SYIEYPositive Net Change
earnings medical medical-devices
WST Stock Up on Q3 Earnings Beat, EPS View Raised on Demand & FX Benefit
by Zacks Equity Research
West Pharmaceutical's strong Q3 beat and raised EPS outlook highlight robust demand, FX tailwinds, and solid growth in Proprietary Products.
BSXPositive Net Change MASINegative Net Change MMSINegative Net Change WSTPositive Net Change
earnings medical medical-devices
Zacks.com featured highlights include The Honest Company, Dutch, AIM ImmunoTech, Masimo and Cognizant Technology Solutions
by Zacks Equity Research
HNST, BROS, AIM, MASI, and CTSH are spotlighted as top-ranked stocks with rising P/E ratios and strong earnings momentum.
CTSHPositive Net Change MASINegative Net Change AIMPositive Net Change HNSTNo Net Change BROSPositive Net Change
computers consumer-discretionary medical medical-devices restaurants
Here's How Henry Schein Is Placed Ahead of Q3 Earnings
by Zacks Equity Research
HSIC heads into Q3 with solid gains expected across Dental, Specialty and Tech segments, though earnings estimates have slipped slightly.
HSICNegative Net Change ANIPPositive Net Change EXASNegative Net Change EHCNegative Net Change
earnings medical medical-devices
Will RVTY Q3 Earnings Reflect Segmental Strength Amid Rising Demand?
by Zacks Equity Research
RVTY's third-quarter results are likely to reflect strong performance in the Life Sciences segment. However, the Diagnostic segment is set to face challenges in China.
MCKNegative Net Change EWNegative Net Change GMEDNegative Net Change RVTYNegative Net Change
medical medical-devices
GEHC Stock Up Following Approval to Boost Hemodynamic Monitoring
by Zacks Equity Research
GE HealthCare secures CE mark for Carevance, advancing scalable, cost-effective monitoring across care settings.
BSXPositive Net Change RMDPositive Net Change MASINegative Net Change GEHCNegative Net Change
medical medical-devices
ISRG Stock Gains on Q3 Earnings & Revenue Beat, Gross Margin Declines
by Zacks Equity Research
Intuitive Surgical's shares jump 17% after Q3 earnings and revenues beat expectations, fueled by surging da Vinci 5 placements and strong global procedure growth.
ISRGNegative Net Change PODDPositive Net Change PAHCNegative Net Change VCYTNegative Net Change
earnings medical medical-devices
Hims & Hers Advances AI-Powered Personalized Digital Healthcare
by Debanjana Dey
HIMS accelerates AI-powered care with new tech leadership, personalized treatments and a major $870 million investment push.
AMWLPositive Net Change HIMSPositive Net Change DOCSPositive Net Change
medical medical-devices
Q3 Earnings Bonanza Pulls a Flat Pre-Market: T, TMO, TSLA, etc.
by Mark Vickery
Q3 earnings reports released yesterday afternoon did not quite have the positive sheen we've seen elsewhere this far into earnings season.
GEPositive Net Change TPositive Net Change IBMPositive Net Change LUVNegative Net Change TMONegative Net Change TSLAPositive Net Change TECKPositive Net Change GEVPositive Net Change
communications earnings electric-vehicles medical-devices tech-stocks
BFLY Q3 Earnings Preview: Strategic Progress Likely to Support Growth
by Zacks Equity Research
Butterfly Network's Q3 earnings may have been shaped by iQ3 adoption, software growth and strategic progress.
IDXXNegative Net Change ANIPPositive Net Change EXASNegative Net Change BFLYPositive Net Change
earnings medical medical-devices
Thermo Fisher's Q3 Earnings & Revenues Top Estimates, Stock Climbs
by Zacks Equity Research
TMO delivers robust Q3 results, fueled by margin growth, new launches and AI-focused strategic initiatives.
TMONegative Net Change PODDPositive Net Change PAHCNegative Net Change VCYTNegative Net Change
earnings medical medical-devices
HIMS Stock Declines Despite Launch of New Specialty in Women's Health
by Zacks Equity Research
Hims & Hers debuts a new women's health specialty, targeting menopause care with personalized treatment plans.
BSXPositive Net Change RMDPositive Net Change MASINegative Net Change HIMSPositive Net Change
medical medical-devices
Allegiant Travel (ALGT) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
ALGTNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Quest Diagnostics Stock Up on Q3 Earnings & Revenue Beat, Margins Rise
by Zacks Equity Research
DGX posts a strong Q3 with revenues and EPS beating estimates, higher margins and an upbeat full-year outlook.
DGXNegative Net Change PODDPositive Net Change PAHCNegative Net Change VCYTNegative Net Change
earnings medical medical-devices
Will ISRG's dV5 Lend Momentum to Top Line During Q3 Earnings?
by Indrajit Bandyopadhyay
Intuitive Surgical's new da Vinci 5 is driving strong hospital upgrades and premium pricing, setting up ISRG for potential top-line momentum in Q3.
SYKNegative Net Change ISRGNegative Net Change ZBHNegative Net Change
medical medical-devices
BDX Launches AI-Enabled Platform to Unify Healthcare Connectivity
by Zacks Equity Research
BD's new AI-driven Incada Platform and upgraded Pyxis Pro system unite connected care, driving its digital healthcare edge.
BDXPositive Net Change MASINegative Net Change MMSINegative Net Change WSTPositive Net Change
medical medical-devices
Zacks.com featured highlights include Red Robin Gourmet Burgers, 10x Genomics, Norwegian Cruise Line, Electromed and Analog Devices
by Zacks Equity Research
Zacks spotlights five efficient stocks Red Robin, 10x Genomics, Norwegian Cruise Line, Electromed, and Analog Devices that excel in turning assets and operations into profits.
ADIPositive Net Change RRGBNegative Net Change ELMDPositive Net Change NCLHPositive Net Change TXGPositive Net Change
consumer-discretionary medical medical-devices restaurants semiconductor
PacBio Aims to Expand Multiomic Capabilities Via Latest Innovations
by Zacks Equity Research
PACB unveils new SPRQ-Nx chemistry to cut sequencing costs and boost multiomic features on Revio and Vega.
ILMNPositive Net Change QGENNegative Net Change PACBNegative Net Change TXGPositive Net Change
medical medical-devices
HQY Expands Access With GLP-1 Telehealth & Direct HSA Platforms
by Zacks Equity Research
HealthEquity rolls out GLP-1 telehealth and direct HSA enrollment platforms, targeting affordability and growth amid rising healthcare costs and regulatory expansion.
CINegative Net Change HQYPositive Net Change HIMSPositive Net Change LFMDNegative Net Change
medical medical-devices
Should You Buy BlackBerry (BB) After Golden Cross?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
BBPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Beam Therapeutics Inc. (BEAM)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
BEAMPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Abbott Q3 Earnings Review: Tariff, Diagnostics Cap Near-Term Gains
by Urmimala Biswas
Abbott posts strong Q3 growth across key segments, but tariff pressures and weak Diagnostics weigh on near-term momentum.
ABTPositive Net Change BSXPositive Net Change MDTPositive Net Change
earnings-estimates-revisions earnings-outlook earnings-preview earnings-report earnings-streak earnings-surprise healthcare medical medical-devices
Stereotaxis Rolls Out Synchrony System in EU and Files for FDA Approval
by Zacks Equity Research
STXS expands its digital surgery vision with the EU launch of its Synchrony System and an FDA submission for market entry.
ISRGNegative Net Change STXSPositive Net Change MBOTPositive Net Change PRCTNo Net Change
medical medical-devices
Buy, Hold or Sell Hologic Stock? Key Insights Ahead of Q4 Earnings
by Moumi Mondal
HOLX's fiscal Q4 2025 earnings may face limits as macro pressures and slow Diagnostics curb momentum.
BSXPositive Net Change MDTPositive Net Change HOLXPositive Net Change
earnings medical medical-devices